Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD.
Keller CW, et al. Among authors: lunemann jd.
Ann Clin Transl Neurol. 2019 Dec;6(12):2586-2594. doi: 10.1002/acn3.50935. Epub 2019 Nov 4.
Ann Clin Transl Neurol. 2019.
PMID: 31682087
Free PMC article.